FDA

Key Takeaways

The U.S. Food and Drug Administration will soon approve leucovorin for children with cerebral folate deficiency and autism symptoms

Research suggests the drug may improve verbal skills, but it is not a cure for autism

Medicaid and CHIP will be required to cover the treatment once approved

TUESDAY, Sept. 23, 2025 (HealthDay News) — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate deficiency.

The U.S. Food and Drug Administration (FDA) is preparing to

The move, expected in the coming weeks, would mark a new use for the drug, which is already prescribed for patients with cancer and some forms of anemia.

Research suggests leucovorin may improve verbal communication in some children, although health lead

See Full Page